Canada
· Delayed Price · Currency is CAD Fennec Pharmaceuticals Statistics
Total Valuation
TSX:FRX has a market cap or net worth of CAD 299.97 million. The enterprise value is 295.41 million.
| Market Cap | 299.97M |
| Enterprise Value | 295.41M |
Important Dates
The last earnings date was Monday, May 12, 2025.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 27.62M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.05% |
| Shares Change (QoQ) | +0.43% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 14.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 30.75 |
| PS Ratio | 6.75 |
| PB Ratio | -35.49 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -14.24 |
| EV / Sales | 6.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.13
| Current Ratio | 5.13 |
| Quick Ratio | 4.55 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.23 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -12.96% |
| Return on Invested Capital (ROIC) | -31.30% |
| Return on Capital Employed (ROCE) | -31.51% |
| Revenue Per Employee | 1.39M |
| Profits Per Employee | -648,514 |
| Employee Count | 32 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 1.73 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.89% in the last 52 weeks. The beta is 0.32, so TSX:FRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | +21.89% |
| 50-Day Moving Average | 8.74 |
| 200-Day Moving Average | 8.14 |
| Relative Strength Index (RSI) | 69.43 |
| Average Volume (20 Days) | 573 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 15.11 |
Income Statement
In the last 12 months, TSX:FRX had revenue of CAD 44.43 million and -20.75 million in losses. Loss per share was -0.76.
| Revenue | 44.43M |
| Gross Profit | 40.11M |
| Operating Income | -17.22M |
| Pretax Income | -20.23M |
| Net Income | -20.75M |
| EBITDA | -16.74M |
| EBIT | -17.22M |
| Loss Per Share | -0.76 |
Balance Sheet
The company has 32.59 million in cash and 27.81 million in debt, giving a net cash position of 4.78 million.
| Cash & Cash Equivalents | 32.59M |
| Total Debt | 27.81M |
| Net Cash | 4.78M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -8.45M |
| Book Value Per Share | -0.31 |
| Working Capital | 49.74M |
Cash Flow
| Operating Cash Flow | -23.55M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 90.27%, with operating and profit margins of -38.76% and -46.71%.
| Gross Margin | 90.27% |
| Operating Margin | -38.76% |
| Pretax Margin | -45.53% |
| Profit Margin | -46.71% |
| EBITDA Margin | -37.68% |
| EBIT Margin | -38.76% |
| FCF Margin | n/a |
Dividends & Yields
TSX:FRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.05% |
| Shareholder Yield | n/a |
| Earnings Yield | -6.92% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on September 5, 2014. It was a reverse split with a ratio of 0.3333333.
| Last Split Date | Sep 5, 2014 |
| Split Type | Reverse |
| Split Ratio | 0.3333333 |
Scores
TSX:FRX has an Altman Z-Score of -3.95. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.95 |
| Piotroski F-Score | n/a |